AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834)
Jump to navigation
Jump to search
Project Q2043834 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING |
Project Q2043834 in Italy |
Statements
15,000.0 Euro
0 references
30,000.0 Euro
0 references
50.0 percent
0 references
25 October 2017
0 references
15 October 2018
0 references
30 December 2019
0 references
ARDIS S.R.L.
0 references
45°11'9.60"N, 9°9'16.70"E
0 references
AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
0 references
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
0 references
UNE PLATE-FORME TECHNOLOGIQUE INNOVANTE POUR LE DÉVELOPPEMENT ET LA COMMERCIALISATION DE TRAITEMENTS ANTICANCÉREUX À BASE D’ANTICORPS SOUTENUS PAR DES TESTS DIAGNOSTIQUES PRÉ-TRAITEMENT (French)
16 December 2021
0 references
EEN INNOVATIEF TECHNOLOGIEPLATFORM VOOR DE ONTWIKKELING EN COMMERCIALISERING VAN ANTILICHAAMGEBASEERDE KANKERTHERAPIEËN ONDERSTEUND DOOR DIAGNOSTISCHE TESTS VOOR DE BEHANDELING (Dutch)
23 December 2021
0 references
EINE INNOVATIVE TECHNOLOGIEPLATTFORM ZUR ENTWICKLUNG UND KOMMERZIALISIERUNG VON ANTIKÖRPER-BASIERTEN KREBSTHERAPEUTIKA, UNTERSTÜTZT DURCH VORBEHANDLUNGSDIAGNOSTIK (German)
24 December 2021
0 references
Identifiers
E17F17000030002
0 references